지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 저널정보
- 아시아태평양암예방학회 Asian Pacific journal of cancer prevention : APJCP Asian Pacific journal of cancer prevention : APJCP 제17권 제7호
- 발행연도
- 2016.1
- 수록면
- 3,173 - 3,177 (5page)
이용수
초록· 키워드
오류제보하기
Background: The Ministry of Public Health (MOPH) in Lebanon provides cancer drugs free of charge for uninsured patients who account for more than half the total case-load. Other categories of cancer care are subsidized under more stringent eligibility criteria. MOPH's large database offers an excellent opportunity to analyze the cost of cancer treatment in Lebanon. Materials and Methods: Using utilization and spending data accumulated at MOPH during 2008-2013, the cost to the public budget of cancer drugs was assessed per case and per drug type. Results: The average annual cost of cancer drugs was 6,475$ per patient. Total cancer drug costs were highest for breast cancer, followed by chronic myeloid leukemia (CML), colorectal cancer, lung cancer, and Non-Hodgkin's lymphoma (NHL), which together represented 74% of total MOPH cancer drug expenditure. The annual average cancer drug cost per case was highest for CML ($31,037), followed by NHL ($11,566). Trastuzumab represented 26% and Imatinib 15% of total MOPH cancer drug expenditure over six years. Conclusions: Sustained increase in cancer drug cost threatens the sustainability of MOPH coverage, so crucial for socially vulnerable citizens. To enhance the bargaining position with pharmaceutical firms for drug cost containment in a small market like Lebanon, drug price comparisons with neighboring countries which have already obtained lower prices may succeed in lowering drug costs.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Medical Costs and Healthcare Utilization among Cancer Decedents in the Last Year of Life in 2009
Cancer Research and Treatment
2016 .01
-
고가 및 희귀 의약품의 급여 절차 및 관리
보건의료기술평가
2020 .01
-
한방항암제의 세계화를 위한 전략
보건의료기술평가
2017 .06
-
암 치료성적 향상을 위한 제안
대한의사협회지
2017 .01
-
The analysis of survival and the proposal of optimized therapeutic drugs through drug response of tissue culture in pancreatic cancer
대한외과학회 학술대회 초록집
2017 .11
-
Socioeconomic Burden of Cancer in Korea from 2011 to 2015
Cancer Research and Treatment
2020 .01
-
Economic Burden of Cancer in Korea during 2000-2010
Cancer Research and Treatment
2015 .01
-
Prediction of Cancer Incidence and Mortality in Korea, 2020
Cancer Research and Treatment
2020 .01
-
Prediction of Cancer Incidence and Mortality in Korea, 2023
Cancer Research and Treatment
2023 .04
-
Prediction of Cancer Incidence and Mortality in Korea, 2022
Cancer Research and Treatment
2022 .04
-
Review of COVID-19 Therapeutics by Mechanism: From Discovery to Approval
Journal of Korean Medical Science
2024 .04
-
유방암 줄기세포 개념 및 제한점
의생명과학
2018 .01
-
Prediction of Cancer Incidence and Mortality in Korea, 2021
Cancer Research and Treatment
2021 .01
-
Layer-by-layer assembled polymeric thin films as prospective drug delivery carriers: design and applications
생체재료학회지
2018 .12
-
Recent advances of nanotechnology for the delivery of anticancer drugs for breast cancer treatment
Journal of Pharmaceutical Investigation
2020 .01
-
Cancer Metabolism: Strategic Diversion from Targeting Cancer Drivers to Targeting Cancer Suppliers
Biomolecules & Therapeutics(구 응용약물학회지)
2015 .01
-
Factors Contributing to Increases in Prescription Drug Expenditures Borne by National Health Insurance in South Korea
Yonsei Medical Journal
2016 .01
-
PDX in novel cancer drug development: a personalized para-clinical model system for precision cancer medicine
한국실험동물학회 학술발표대회 논문집
2016 .08
-
Strategies for Appropriate Patient-centered Care to Decrease the Nationwide Cost of Cancers in Korea
예방의학회지
2017 .07
이 논문의 저자 정보
최근 본 자료
댓글(0)
0